Oxalic Acid

Oxalic Acid

SCHEMBL1013866

CCCCCC(=O)C=C(C)C.O=C(O)C(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.48
FNTA P49354 2/20 0.47
FNTB P49356 2/20 0.47
TRPA1 O75762 1/20 0.47
THRB P10828 1/20 0.47
PGGT1B P53609 1/20 0.47
PPARG P37231 9/20 0.46
PPARA Q07869 9/20 0.46
GPR84 Q9NQS5 7/20 0.46
PPARD Q03181 7/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
PTPN1 P18031 3/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL454224 0.94 TRPA1 (0.52) AKR1B1TRPA1PPARGPPARAGPR84
SCHEMBL11746072 0.91 CES2 (0.52) TRPA1PPARGPPARAGPR84PPARD
Ammonia Solution, Strong SCHEMBL27538867 0.91 TRPA1 (0.50) AKR1B1TRPA1PPARGPPARAGPR84
SCHEMBL17867061 0.91 CES2 (0.52) TRPA1PPARGPPARAGPR84PPARD
SCHEMBL4422427 0.91 CES2 (0.52) TRPA1PPARGPPARAGPR84PPARD
SCHEMBL11747932 0.91 CES2 (0.52) TRPA1PPARGPPARAGPR84PPARD
SCHEMBL3912771 0.91 CES2 (0.52) TRPA1PPARGPPARAGPR84PPARD
SCHEMBL3635304 0.87 CES1 (0.48) AKR1B1TRPA1PPARGPPARAGPR84
SCHEMBL27580129 0.83 AKR1B1 (0.48) AKR1B1FNTAFNTBTRPA1THRB
SCHEMBL25409775 0.82 PPARG (0.50) AKR1B1FNTAFNTBTHRBPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4716679-A2 AGRICULTURAL COMPOSITION COMPRISING SURFACTANT(S) AND METHOD OF USE THEREOF Hercules LLC (US) 2026-04-01 EP disclosed
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION FIRMENICH & CIE (CH) 2026-03-12 US disclosed
EP-4704575-A2 HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, SALTS AND ITS AGRICULTURAL COMPOSITIONS AND METHODS OF USE ISP Investments LLC (US) 2026-03-11 EP disclosed
WO-2026044006-A1 MODIFIED STARCH COMPOUNDS AND USES THEREOF ISP INVESTMENTS LLC (US) 2026-02-26 WO disclosed
EP-4683510-A1 HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND AGRICULTURAL COMPOSITIONS THEREOF ISP Investments LLC (US) 2026-01-28 EP disclosed
EP-4646109-A2 NATURAL LIPID PARTICLE FORMULATIONS FOR AGRICULTURAL APPLICATIONS Invaio Sciences, Inc. (US) 2025-11-12 EP disclosed
US-12409137-B2 Modification of plant messenger packs with charged lipids FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) 2025-09-09 US disclosed
CN-113905612-B Arthropod control composition 弗门尼舍有限公司 2025-04-08 CN disclosed
WO-2025058958-A1 pH ADJUSTER COMPRISING POLYAMINE-LACTONE/LACTIDE BASED REACTION PRODUCT(S) AND COMPOSITIONS THEREOF ISP INVESTMENTS LLC (US) 2025-03-20 WO disclosed
US-20250002941-A1 A BACTERIA-DERIVED LIPID COMPOSITION AND USE THEREOF SAIL BIOMEDICINES, INC. 2025-01-02 US disclosed
WO-2003079786-A1 DIHYDRONEPETALACTONE AS INSECT REPELLENT E. I. DU PONT DE NEMOURS AND COMPANY (US) 2003-10-02 WO disclosed
EP-1028704-B1 PERSONAL CARE COMPOSITIONS PROCTER & GAMBLE (US) 2002-03-20 EP disclosed
US-5965115-A EMULSION OF POLYORGANOSILOXANE PARTICLES, POLYETHERSILOXANE BLOCK POLYMER SURFACTANT IN A CARRIER OF WATER OR A WATER SOLUBLE ORGANIC SOLVENT, AND SECOND SOLVENT OF C1-C3 KETONES, ETHERS OR ALCOHOLS; COPOLYMER SURFACTANT IMPROVES STABILITY THE PROCTER & GAMBLE COMPANY (US) 1999-10-12 US disclosed
EP-0167265-B1 Method of repelling insects COULSTON INT CORP (US) 1995-12-20 EP disclosed
EP-0666027-A1 Method of repelling insects COULSTON INTERNATIONAL CORPORATION (US) 1995-08-09 EP disclosed
US-4869896-A N,N-DIETHL-M-TOLUAMIDE AND BICYCLIC LACTONE ANGUS CHEMICAL COMPANY (US) 1989-09-26 US disclosed
EP-0167266-B1 INSECT REPELLENT COMPOSITION AND METHOD OF REPELLING INSECTS ANGUS CHEMICAL COMPANY (US) 1989-08-02 EP disclosed
US-4663346-A Insect repellent ANGUS CHEMICAL COMPANY (US) 1987-05-05 US disclosed
EP-0167266-A1 Insect repellent composition and method of repelling insects ANGUS CHEMICAL COMPANY (US) 1986-01-08 EP disclosed
EP-0167265-A1 Method of repelling insects COULSTON INTERNATIONAL CORPORATION (US) 1986-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION CNOT9, MSL1, MT-CO2 AKR1B1 2978/4885FNTA 1933/4885FNTB 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.